News from CNBC Business
What is your interest today?
Bitcoin
Crypto
Btc
Tariffs
Ceo
Cryptocurrency
Crypto Assets
Stocks
Investors
Stock
Shares
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Blockchain
Sec
Stablecoin
Eth
Etf
Trade
Earnings
Revenue
Solana
Index
Bse
China
Coinbase
Ipo
Token
Wall Street
Nasdaq
Trade War
Usd
Inflation
Interest Rates
Economy
Profit
Digital Assets
Sensex
Sp 500
Gold
Nvidia
Nse
Tesla
Federal Reserve
Binance
Bse Sensex
Income Tax
Checks
Franchise
Homebuilder
Housing Policy
Superannuation
Bitcoin Satoshi Vision
Stolen Funds
Huione Group
Social Casino
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Cnbc Business headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • May 01, 2025
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS has raised its full-year earnings forecast to between $6 and $6.20 per share due to positive developments in its insurance sector, surpassing previous expectations.
Read Full Article →
CNBC Business • May 01, 2025
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, improving accessibility for patients on its drug plans and potentially increasing the treatment's market presence...
Read Full Article →